Pull out the waterboards – answers needed in bomb grade uranium sale case
WASHINGTON — It was one of the most serious cases of smuggling of nuclear material in recent years: A Russian man, authorities allege, tried to sell a small amount of nuclear-bomb grade uranium in a plastic bag in his jacket pocket.
The buy that took place last summer, it turned out, was a setup by Republic of Georgia authorities, with the help of the CIA. Their quiet sting operation — neither U.S. nor Georgian officials have publicized it — is an unsettling reminder about the possibility of terrorists acquiring nuclear bomb-making material on the black market.
No evidence suggests this particular case was terrorist-related.
Maybe I’m cynical or something, but I just get the feeling that anyone that’s trying to sell uranium on the down low would possibly be terrorist-related – or at the very least a terrorist supplier wannabe.
Authorities say they do not know how the man acquired the nuclear material or if his claims of access to much larger quantities were true. He and three Georgian accomplices are in Georgian custody and not cooperating with investigators.
Waterboards – baby…
Alzheimer’s vaccine ‘in a patch’
I have a personal interest in this story. You’re probably thinking that I’m concerned about older loved ones in my life (or myself). Actually, it’s my four year old son with whom I’m concerned. He has Down syndrome and 25% of adults with Down syndrome will develop Alzheimer’s disease by the age of 40. 65% of those with Down syndrome who live to age 60 will have the disease and all autopsies of people with Down syndrome have shown brain patterns indicative of Alzheimer disease.
This vaccine patch could be very good news for him and other children with Down syndrome.
A patch which delivers a vaccine against Alzheimer’s disease through the skin has been shown to be safe and effective, a study has found.
University of South Florida researchers reported the patch was able to clear brain-damaging plaques from mice.
More:
Alzheimer’s is linked with the build up of a protein called beta amyloid in the brain, where it clumps together to form damaging plaques.
The vaccine – given transdermally – works by triggering the immune system to recognise beta amyloid protein, attack it and break it down.


